24/7 Field Service Engineer Hotline: +1-800-665-1000 UDI Look-up · GPO Contracts: Premier · Vizient · HealthTrust
Clinical planning

Clinical note: mlnlycke-wound-care-vs-budget-dressings-a-procurement-manager039s-honest-cost-comparison-138

Posted on 2026-08-31 by Jane Smith
Clinical planning article header

When I first took over procurement for our hospital system, I thought the math was simple. Same dressing category, similar specs on paper, go with the cheaper quote. Everything I'd read about buying medical supplies said the premium brands were charging for the name, not the product.

Six years and roughly $180,000 in wound care purchases later, I know that was wrong. Not in every case — but in the ones that mattered most.

So if you're weighing Mölnlycke wound care products against budget alternatives, here's the comparison I wish someone had handed me back then. I'll walk through four dimensions, show you where my assumptions fell apart, and tell you exactly where I'd still pick the budget option.

The comparison framework

This is really an A vs. B decision that plays out in every hospital, clinic, and surgery center:

  • Option A: Buy from a specialist manufacturer like Mölnlycke Healthcare US LLC, the entity behind Mölnlycke's US operations, and pay a premium
  • Option B: Buy equivalent-looking dressings, drapes, and surgical supplies from a lower-priced supplier

I'll compare them on four dimensions: clinical performance, total cost of ownership, supplier reliability and infection control, and staff workflow. The goal isn't to declare one winner — it's to help you pick the right option for your specific setup.

Dimension 1: Clinical performance — Safetac vs. traditional adhesives

This is the comparison that matters most, and it's the one a unit-price comparison completely misses.

Mölnlycke's wound care line — Mepilex, Mepiform, Melgisorb — uses Safetac silicone adhesive technology. If you've ever peeled a Mepilex dressing off a patient's skin and watched it release without pulling at the wound or the surrounding skin, you know what I'm talking about. The adhesive seals gently and doesn't strip skin on removal.

Traditional adhesive dressings do stick. Hard. I've stood in on dressing changes where a nurse peeled off a generic foam dressing and took a layer of fragile skin with it. That's not just uncomfortable — it creates micro-tears, delays healing, and opens the door for complications.

People assume that because both products say "foam dressing" on the box, they're basically interchangeable. That's the surface illusion. The adhesive interface — the part that actually touches the patient — is where the real difference sits. And it's usually where manufacturers cut costs first.

The clinical evidence backs this up. Safetac technology was designed for atraumatic removal, meaning less pain at dressing change and less skin stripping compared to traditional adhesives. For elderly patients or anyone with fragile skin, that's the difference between a manageable case and a recurring one.

Conclusion on clinical performance: if you're treating wounds in patients with fragile skin or complex healing needs, the adhesive technology isn't a luxury. It's the core function of the product.

Dimension 2: Total cost — what the price tag misses

Here's the dimension where I got burned early, and where I only learned the lesson after doing the full cost analysis.

Let me walk through a real comparison from my cost tracking spreadsheet. Say a budget foam dressing costs $0.80 per unit. A Mepilex dressing runs about $2.20. The budget option looks like the obvious choice, right? $1.40 less per dressing adds up fast.

But here's what I started tracking when I stopped looking at just the purchase order:

  • The budget dressing needed changing every 2 days — about 15 changes over a 30-day treatment course
  • The Mepilex dressing stayed in place for 3–4 days, meaning 8–9 changes for the same period
  • Each dressing change costs roughly $6–8 in nursing time (that was the rate in 2023; probably higher now)
  • The budget dressing occasionally caused skin stripping that required extra treatment — I didn't count that in the math below, but it exists

Total cost per patient for 30 days:

Budget dressing: 15 changes × ($0.80 + $7.00 average nursing time) = $117

Mepilex: 8.5 changes × ($2.20 + $7.00 average nursing time) = $78.20

Wait, let me double-check that. 15 × 7.80 = 117. 8.5 × 9.20 = 78.20. Yeah. The dressing that costs nearly three times as much per unit actually ends up costing about $39 less per patient course — before even counting complications from skin damage.

I only fully believed this math after getting burned once. During my first year, I approved a bulk order of budget dressings to "save" about $4,000 per quarter. By the end of that quarter, our wound care team was reporting more frequent changes, slower healing, and two patients who developed complications. We quietly switched back to Mölnlycke and the numbers normalized. I built a cost calculator after that, because I don't like making the same mistake twice.

Conclusion on total cost: the lowest unit price rarely equals the lowest cost per treatment episode. This is one of those things procurement people nod along to in training, then have to live through once to actually believe.

Dimension 3: Supplier reliability and infection control

This dimension is less visible, but it's the one that keeps me up at night.

Mölnlycke Healthcare US LLC isn't a faceless supplier. It's a major medical device company with FDA-registered operations, documented sterilization processes, clear lot traceability, and a name that's accountable if something goes wrong. When you buy from them, you get a regulatory paper trail your compliance team can verify.

Budget suppliers in the medical space are a mixed bag. Some are fine. Others shift product sourcing between lots without notice, and you find out when a batch of dressings behaves differently than the last one. That variability is hard to put on a spreadsheet, but it's a real cost in a hospital environment.

Here's what I mean when I say infection control is a system, not a single product. Take the autoclave question that comes up whenever we onboard new staff — "how does an autoclave work?" The short answer: it uses saturated steam under pressure, typically reaching 121°C in a gravity displacement cycle or 134°C in a pre-vacuum cycle, to destroy microorganisms on surgical instruments. But the longer, more useful answer is that an autoclave is only as reliable as its maintenance, its validation testing, and the quality of the items you put into it.

The same logic applies to surgical drapes and gowns. When I compare Mölnlycke's Barrier line to generic alternatives, the meaningful comparison isn't just price per unit — it's whether the material offers the same measured barrier performance against fluid strike-through and microbial penetration. With surgical site infections costing anywhere from $10,000 to $30,000 per case to treat (numbers from our finance department's internal analysis), a slightly cheaper drape that underperforms isn't a saving. It's a gamble.

I've seen the same pattern with capital equipment. When our surgical team evaluated an ultrasonic surgical aspirator a few years back, I initially pushed for the lower-priced unit from a less established manufacturer. Same logic as the dressings: "it does the same thing." But after factoring in the service contract, the probe replacement schedule, and training hours, the cheaper unit ended up more expensive by year two. Same story with fetal monitors when we upgraded the birthing center — the budget models had calibration requirements that quietly ate the upfront savings.

The lesson that kept repeating: in medical procurement, the purchase price is often the smallest part of the cost. The reliability of the supplier behind that price is what actually moves your budget over time.

Conclusion on reliability: when you buy from a manufacturer with established quality systems and traceability, you're paying for predictability. In a hospital, predictability has a real dollar value.

Dimension 4: Staff workflow — the cost that doesn't show up on an invoice

I almost left this dimension out because it's hard to put a number on. But any procurement person who's spent time on a ward knows it's real.

Nurses notice when a dressing is stiff, awkward to apply, or doesn't stay put. They notice when a surgical gown doesn't breathe or a drape doesn't absorb the way it should. Those small frictions add up across every single patient interaction.

When we standardized on Mölnlycke dressings for our wound care ward in 2022, the head nurse put it simply:

"Twenty minutes per shift that I get back."

Not because nurses were rushing — because Safetac dressings were easier to position and remove cleanly. Over a ward with 20+ post-operative patients, that translated directly into hours of nursing time per week. Hours that didn't show up on a supply invoice, but definitely showed up on the payroll report.

That said, I should add a caveat: this is specific to our use case. We're a hospital handling surgical and chronic wounds. If you run a small clinic that mainly sees minor abrasions, the workflow difference is negligible. You probably don't need that level of product sophistication.

Conclusion on workflow: premium products earn their keep when staff interact with them constantly. For low-volume, low-complexity settings, the workflow argument disappears.

Where I'd still buy the budget option

Alright, I said this wouldn't be a Mölnlycke ad, so let me follow through on that.

Here's where the budget option genuinely makes sense:

  • Simple wounds in healthy patients. Minor abrasions, superficial cuts, clean post-surgical wounds in younger patients who heal fast anyway. The advanced adhesive technology won't change the outcome enough to justify the premium.
  • Low-volume clinics. If you're not doing many dressing changes, the nursing-time savings never materialize. The total cost difference is small enough that unit price can be the deciding factor.
  • When the clinical team signs off in writing. If your clinicians review the product specs and confirm the budget option meets their protocols — not "looks similar," but actually meets them — then buy with confidence.

And where Mölnlycke is the more responsible choice:

  • Chronic, surgical, or burn wounds. Healing time, skin integrity, and dressing change frequency directly affect outcomes and length of stay.
  • Fragile skin populations. Elderly patients, neonates, patients on steroids — anyone whose skin won't tolerate aggressive adhesives.
  • Anywhere infection risk is high. Surgical departments, ICU, orthopedics. That includes the drapes and gowns decision, not just dressings.
  • When you've actually run the TCO numbers. If your own cost analysis shows the premium option keeps per-patient costs lower, that's your answer.

Bottom line

This comparison was never really about Mölnlycke versus generic dressings. It's about unit price versus total cost across a full treatment episode, and about how much predictability is worth in a clinical setting.

For some cases, the budget option is genuinely fine. For many hospital use cases, the specialist product is the more financially sound decision — even at two or three times the unit price. I didn't start out believing that. I got there by tracking $180,000 in wound care spending over six years and watching where the money actually went.

The cheapest option on the shelf feels like the safe choice in any procurement meeting. But in healthcare, the safe choice is the one that measurably protects healing outcomes, nursing time, and the hospital's own reputation. That's the comparison that matters.

Permalink Ask a Specialist
Jane Smith

Jane Smith

I’m Jane Smith, a senior content writer with over 15 years of experience in the packaging and printing industry. I specialize in writing about the latest trends, technologies, and best practices in packaging design, sustainability, and printing techniques. My goal is to help businesses understand complex printing processes and design solutions that enhance both product packaging and brand visibility.